Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 5, 2006, Pages 1189-1191

  Viola, Marinella ^a   Quaratino, Donato ^b   Volpetti, Sabrina ^a   Gaeta, Francesco ^a   Romano, Antonino ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CHLORPHENIRAMINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; KETOPROFEN; KETOROLAC; METHYLPREDNISOLONE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; PARACETAMOL; PARECOXIB; PROPYPHENAZONE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PYRAZOLONE DERIVATIVE; ROFECOXIB; VALDECOXIB;

ADULT; AGED; ANALGESIA; ANGIONEUROTIC EDEMA; ASTHMA; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; DYSPNEA; FEMALE; HUMAN; LETTER; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHINITIS; SINGLE BLIND PROCEDURE; URTICARIA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNE TOLERANCE; ISOXAZOLES; MALE; MIDDLE AGED;

EID: 33646479150     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.02.011     Document Type: Letter

References (11)

1. Mastalerz L., Setkowicz M., Sanak M., and Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 113 (2004) 771-775
2. Czerniawska-Mysik G., and Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 36 (1981) 381-384
3. Himly M., Jahn-Schmid B., Pittertschatscher K., Bohle B., Grubmayr K., Ferreira F., et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 111 (2003) 882-888
4. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111 (2003) 913-921
5. Szczeklik A., Nizankowska E., Bochenek G., Nagraba K., Mejza F., and Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 31 (2001) 219-225
6. Stevenson D.D., and Simon R.A. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 108 (2001) 47-51
7. Viola M., Quaratino D., Gaeta F., Caringi M., Valluzzi R., Caruso C., et al. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 137 (2005) 145-150
8. Sánchez-Borges M., Caballero-Fonseca F., and Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 95 (2005) 154-158
9. Stevenson D.D., Sánchez-Borges M., and Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 87 (2001) 177-180
10. Scala E., Giani M., Pirrotta L., Guerra E.C., Locanto M., De Pità O., et al. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. J Allergy Clin Immunol 107 (2001) 557
11. Looney Y., O'Shea A., and O'Dwyer R. Severe bronchospasm after parenteral parecoxib: cyclooxygenase-2 inhibitors: not answer yet. Anesthesiology 102 (2005) 473-475